QuickView for glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity (biogroup)

1. Glomeruli from patients with focal segmental glomerulosclerosis or minimal change disease
2. Hepatocellular carcinoma (HCC) and cholangiocarcinoma (CC) expression profiles
3. L1000 CMAP - Breast carcinoma BT20 cells treated with small molecule perturbagens
4. L1000 CMAP - Neural progenitor NPC cells treated with small molecule perturbagens
5. L1000 CMAP - Motor neuron MNEU.E cells treated with small molecule perturbagens

There were no matches for glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity

There were no clinical trials for glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity